Plasma-Based Genotyping Aids Targeted Tx of Metastatic NSCLC

THURSDAY, Oct. 18, 2018 -- Integration of plasma next-generation sequencing (NGS) into the routine management of metastatic non-small cell lung cancer (NSCLC) results in an increase in the detection of therapeutically targetable mutations, according...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news